Mining for humoral correlates of HIV control and latent reservoir size
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mining for humoral correlates of HIV control and latent reservoir size
Authors
Keywords
Antibodies, HIV, Biomarkers, Viral load, Viremia, Viral replication, Antiretroviral therapy, Biophysics
Journal
PLoS Pathogens
Volume 16, Issue 10, Pages e1008868
Publisher
Public Library of Science (PLoS)
Online
2020-10-14
DOI
10.1371/journal.ppat.1008868
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Optimization and qualification of an Fc Array assay for assessments of antibodies against HIV-1/SIV
- (2018) Eric P. Brown et al. JOURNAL OF IMMUNOLOGICAL METHODS
- High‐resolution definition of humoral immune response correlates of effective immunity against HIV
- (2018) Galit Alter et al. Molecular Systems Biology
- HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies
- (2018) Simone I. Richardson et al. PLoS Pathogens
- Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV
- (2018) Margaret E. Ackerman et al. NATURE MEDICINE
- B-cell responses to HIV infection
- (2017) Susan Moir et al. IMMUNOLOGICAL REVIEWS
- Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles
- (2017) Eric P. Brown et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Can Biomarkers Advance HIV Research and Care in the Antiretroviral Therapy Era?
- (2017) Amy C Justice et al. JOURNAL OF INFECTIOUS DISEASES
- Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?
- (2017) Michaela Seeling et al. Nature Reviews Rheumatology
- The Immunoregulatory Roles of Antibody Glycosylation
- (2017) Madeleine F. Jennewein et al. TRENDS IN IMMUNOLOGY
- The Alphabet Soup of HIV Reservoir Markers
- (2017) Radwa R. Sharaf et al. Current HIV/AIDS Reports
- Multiple Origins of Virus Persistence during Natural Control of HIV Infection
- (2016) Eli A. Boritz et al. CELL
- Maintenance of HIV-Specific Memory B-Cell Responses in Elite Controllers Despite Low Viral Burdens
- (2016) Clarisa M. Buckner et al. JOURNAL OF INFECTIOUS DISEASES
- Human Galectin-9 Is a Potent Mediator of HIV Transcription and Reactivation
- (2016) Mohamed Abdel-Mohsen et al. PLoS Pathogens
- Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV
- (2016) Alison L. Hill et al. PLoS Pathogens
- Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control
- (2016) Margaret E. Ackerman et al. PLoS Pathogens
- Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology
- (2015) Amy W. Chung et al. CELL
- Microscale purification of antigen-specific antibodies
- (2015) Eric P. Brown et al. JOURNAL OF IMMUNOLOGICAL METHODS
- A method for high-throughput, sensitive analysis of IgG Fc and Fab glycosylation by capillary electrophoresis
- (2015) Alison E. Mahan et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Comprehensive serological profiling of human populations using a synthetic human virome
- (2015) G. J. Xu et al. SCIENCE
- Towards an HIV-1 cure: measuring the latent reservoir
- (2015) Katherine M. Bruner et al. TRENDS IN MICROBIOLOGY
- Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines
- (2014) A. W. Chung et al. Science Translational Medicine
- Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination
- (2014) N. L. Yates et al. Science Translational Medicine
- HIV-1 DNA predicts disease progression and post-treatment virological control
- (2014) James P Williams et al. eLife
- Biomarker reveals HIV's hidden reservoir
- (2014) Leslie R Cockerham et al. eLife
- Insights into B cells and HIV-specific B-cell responses in HIV-infected individuals
- (2013) Susan Moir et al. IMMUNOLOGICAL REVIEWS
- Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity
- (2013) Margaret E. Ackerman et al. JOURNAL OF CLINICAL INVESTIGATION
- Glycans Are a Novel Biomarker of Chronological and Biological Ages
- (2013) Jasminka Krištić et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection
- (2012) Leia H. Wren et al. IMMUNOLOGY
- Acute Plasma Biomarkers of T Cell Activation Set-Point Levels and of Disease Progression in HIV-1 Infection
- (2012) Anne-Sophie Liovat et al. PLoS One
- Correlation Between Circulating HIV-1 RNA and Broad HIV-1 Neutralizing Antibody Activity
- (2011) Mohammad M Sajadi et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples
- (2010) Margaret E. Ackerman et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Biomarkers of immune dysfunction in HIV
- (2010) Daniel E Nixon et al. Current Opinion in HIV and AIDS
- Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers
- (2009) Olivier Lambotte et al. AIDS
- Human Immunodeficiency Virus Type 1-Specific CD8+ T-Cell Responses during Primary Infection Are Major Determinants of the Viral Set Point and Loss of CD4+ T Cells
- (2009) H. Streeck et al. JOURNAL OF VIROLOGY
- Breadth of Human Immunodeficiency Virus-Specific Neutralizing Activity in Sera: Clustering Analysis and Association with Clinical Variables
- (2009) N. A. Doria-Rose et al. JOURNAL OF VIROLOGY
- Specificity and affinity of human Fc receptors and their polymorphic variants for human IgG subclasses
- (2008) P. Bruhns et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now